OIG Special Fraud Alerts: Risks, Implications & Solutions

OIG issued a Special Fraud Alert on November 16th, 2020

The Alert highlighted the fraud and abuse risks associated with the offer, payment, solicitation, or receipt of remuneration relating to Speaker Programs by Pharmaceutical and Medical Device Companies.

Our Guest Speakers will address the impact of the OIG Special Fraud Alert in conducting the programs, managing meal spend, setting up Key Risk Indicators and Monitoring for them. Join us for this Three Part Webinar Series arranged in collaboration with Attorneys, Event Managers, Solution Providers, Speaker Program Monitors and Industry Experts.

Heidi Kocher, Esq. has studied these regulatory changes, and she will be walking you through these new regulations in an information session. Over 300 of your colleagues have registered for her sessions in the recent past. Please join her by registering for the webinar here.

Agenda:

• Discuss Legal Implications that Speaker Program Managers must consider with Virtual Events
• Best Practices followed by Drug and Device Manufacturers for Mitigating Risk
• Share findings from surveys conducted with Pharmaceutical Compliance teams as they manage the new Virtual Setting

The 60 minutes session will include 15 minutes to answer your questions.

Date: Tuesday, October 12th, 2021
Time: 1pm EST, 12pm CST, 10am PST